Skip to main content
OpenTrials

Clinical trial condition

Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

Explore clinical trials studying Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 trial results

Completed

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

NCT02098343

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 55 locations
View Trial Details

Related conditions